STOCK TITAN

CME Group’s Julie Winkler proposes $3.08M share sale

The notice lists 357,930,746 CME Group shares outstanding alongside the proposed sale’s aggregate market value of $3,075,614.91.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

CME Group Inc. officer Julie Winkler reported a proposed sale of 10,079 common shares, with an aggregate market value of $3,075,614.91 and an approximate sale date of November 2, 2026. Morgan Stanley Smith Barney LLC is listed as the broker, and NASDAQ as the exchange. The listed acquisition entries include 3,578 performance shares acquired March 15, 2024, and 2,043 performance shares acquired March 15, 2025.

Common shares proposed for sale 10,079 shares Approximate sale date November 2, 2026
Aggregate market value $3,075,614.91 Proposed common-share sale
Issuer shares outstanding 357,930,746 shares Listed in the securities information
Rule 144 regulatory
"definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock financial
"Restricted Stock acquired from Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Performance Shares financial
"Performance Shares acquired from Issuer"
Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CME shares did Julie Winkler report for sale?

Julie Winkler reported a proposed sale of 10,079 CME Group common shares. The approximate sale date listed is November 2, 2026.

Which acquisition lots are listed for Julie Winkler’s proposed CME sale?

The entries are 443 restricted shares acquired September 16, 2020; 544 restricted shares acquired September 15, 2021; 455 restricted shares acquired September 16, 2021; 1,494 performance shares acquired March 15, 2022; 564 and 487 restricted shares acquired September 15, 2022; 471 restricted shares acquired September 16, 2022; 3,578 performance shares acquired March 15, 2024; and 2,043 performance shares acquired March 15, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading